Lv1
58 积分 2023-12-20 加入
Abstract 2642: BL-B01D1, a novel EGFR×HER3-targeting ADC, demonstrates robust anti-tumor efficacy in preclinical evaluation
1个月前
已关闭
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia
1个月前
已完结
Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
2个月前
已完结
The antibody–drug conjugate landscape
4个月前
已完结
The Effects of HER2 on CDK4/6 Activity in Breast Cancer
11个月前
已完结
Mutations linked to chemotherapy resistance in colorectal cancer
11个月前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
11个月前
已完结
Colorectal cancer
11个月前
已完结
皖公网安备34019202002308
